These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
541 related articles for article (PubMed ID: 10759209)
1. Molecular characterization of the ligand-receptor interaction of the neuropeptide Y family. Cabrele C; Beck-Sickinger AG J Pept Sci; 2000 Mar; 6(3):97-122. PubMed ID: 10759209 [TBL] [Abstract][Full Text] [Related]
2. Characterization of a new neuropeptide Y Y5 agonist radioligand: [125I][cPP(1-7), NPY(19-23), Ala31, Aib32, Gln34]hPP. Dumont Y; Thakur M; Beck-Sickinger A; Fournier A; Quirion R Neuropeptides; 2004 Aug; 38(4):163-74. PubMed ID: 15337369 [TBL] [Abstract][Full Text] [Related]
3. Identification of positions in the human neuropeptide Y/peptide YY receptor Y2 that contribute to pharmacological differences between receptor subtypes. Fällmar H; Åkerberg H; Gutiérrez-de-Terán H; Lundell I; Mohell N; Larhammar D Neuropeptides; 2011 Aug; 45(4):293-300. PubMed ID: 21696823 [TBL] [Abstract][Full Text] [Related]
4. Modeling of neuropeptide receptors Y1, Y4, Y5, and docking studies with neuropeptide antagonist. Jois SD; Nagarajarao LM; Prabhakaran M; Balasubramaniam A J Biomol Struct Dyn; 2006 Apr; 23(5):497-508. PubMed ID: 16494499 [TBL] [Abstract][Full Text] [Related]
5. Characterization of neuropeptide Y-induced feeding in mice: do Y1-Y6 receptor subtypes mediate feeding? Iyengar S; Li DL; Simmons RM J Pharmacol Exp Ther; 1999 May; 289(2):1031-40. PubMed ID: 10215684 [TBL] [Abstract][Full Text] [Related]
6. Characterization of the peptide binding requirements for the cloned human pancreatic polypeptide-preferring receptor. Gehlert DR; Schober DA; Beavers L; Gadski R; Hoffman JA; Smiley DL; Chance RE; Lundell I; Larhammar D Mol Pharmacol; 1996 Jul; 50(1):112-8. PubMed ID: 8700103 [TBL] [Abstract][Full Text] [Related]
7. GPC receptors and not ligands decide the binding mode in neuropeptide Y multireceptor/multiligand system. Lindner D; van Dieck J; Merten N; Mörl K; Günther R; Hofmann HJ; Beck-Sickinger AG Biochemistry; 2008 Jun; 47(22):5905-14. PubMed ID: 18457425 [TBL] [Abstract][Full Text] [Related]
8. Cloning and characterization of rabbit neuropeptide Y receptor subtypes. Umeda T; Kanatani A; Iwaasa H Peptides; 2009 Aug; 30(8):1441-7. PubMed ID: 19481128 [TBL] [Abstract][Full Text] [Related]
9. Molecular recognition of the NPY hormone family by their receptors. Lindner D; Stichel J; Beck-Sickinger AG Nutrition; 2008 Sep; 24(9):907-17. PubMed ID: 18725086 [TBL] [Abstract][Full Text] [Related]
10. Mutagenesis of human neuropeptide Y/peptide YY receptor Y2 reveals additional differences to Y1 in interactions with highly conserved ligand positions. Akerberg H; Fällmar H; Sjödin P; Boukharta L; Gutiérrez-de-Terán H; Lundell I; Mohell N; Larhammar D Regul Pept; 2010 Aug; 163(1-3):120-9. PubMed ID: 20471432 [TBL] [Abstract][Full Text] [Related]
11. Strongly altered receptor binding properties in PP and NPY chimeras are accompanied by changes in structure and membrane binding. Lerch M; Kamimori H; Folkers G; Aguilar MI; Beck-Sickinger AG; Zerbe O Biochemistry; 2005 Jun; 44(25):9255-64. PubMed ID: 15966750 [TBL] [Abstract][Full Text] [Related]
12. Studies of the structure of the N-terminal domain from the Y4 receptor - a G protein-coupled receptor - and its interaction with hormones from the NPY family. Zou C; Kumaran S; Markovic S; Walser R; Zerbe O Chembiochem; 2008 Sep; 9(14):2276-84. PubMed ID: 18767100 [TBL] [Abstract][Full Text] [Related]
13. Identification and distribution of mRNA encoding the Y1, Y2, Y4, and Y5 receptors for peptides of the PP-fold family in the rat intestine and colon. Goumain M; Voisin T; Lorinet AM; Laburthe M Biochem Biophys Res Commun; 1998 Jun; 247(1):52-6. PubMed ID: 9636652 [TBL] [Abstract][Full Text] [Related]
14. Evidence that the inhibition of luteinizing hormone secretion exerted by central administration of neuropeptide Y (NPY) in the rat is predominantly mediated by the NPY-Y5 receptor subtype. Raposinho PD; Broqua P; Pierroz DD; Hayward A; Dumont Y; Quirion R; Junien JL; Aubert ML Endocrinology; 1999 Sep; 140(9):4046-55. PubMed ID: 10465275 [TBL] [Abstract][Full Text] [Related]
15. Neuropeptide-Y and Y-receptors in the autocrine-paracrine regulation of adrenal gland under physiological and pathophysiological conditions (Review). Spinazzi R; Andreis PG; Nussdorfer GG Int J Mol Med; 2005 Jan; 15(1):3-13. PubMed ID: 15583821 [TBL] [Abstract][Full Text] [Related]
16. Neuropeptide Y suppresses absence seizures in a genetic rat model primarily through effects on Y receptors. Morris MJ; Gannan E; Stroud LM; Beck-Sickinger AG; O'Brien TJ Eur J Neurosci; 2007 Feb; 25(4):1136-43. PubMed ID: 17331209 [TBL] [Abstract][Full Text] [Related]
17. Structural similarities of micelle-bound peptide YY (PYY) and neuropeptide Y (NPY) are related to their affinity profiles at the Y receptors. Lerch M; Mayrhofer M; Zerbe O J Mol Biol; 2004 Jun; 339(5):1153-68. PubMed ID: 15178255 [TBL] [Abstract][Full Text] [Related]
18. Binding of chimeric NPY/galanin peptides M32 and M242 to cloned neuropeptide Y receptor subtypes Y1, Y2, Y4, and Y5. Berglund MM; Saar K; Lundell I; Langel U; Larhammar D Neuropeptides; 2001; 35(3-4):148-53. PubMed ID: 11884204 [TBL] [Abstract][Full Text] [Related]
19. L-152,804: orally active and selective neuropeptide Y Y5 receptor antagonist. Kanatani A; Ishihara A; Iwaasa H; Nakamura K; Okamoto O; Hidaka M; Ito J; Fukuroda T; MacNeil DJ; Van der Ploeg LH; Ishii Y; Okabe T; Fukami T; Ihara M Biochem Biophys Res Commun; 2000 May; 272(1):169-73. PubMed ID: 10872822 [TBL] [Abstract][Full Text] [Related]
20. Neuropeptide Y and the nonpeptide antagonist BIBP 3226 share an overlapping binding site at the human Y1 receptor. Sautel M; Rudolf K; Wittneben H; Herzog H; Martinez R; Munoz M; Eberlein W; Engel W; Walker P; Beck-Sickinger AG Mol Pharmacol; 1996 Aug; 50(2):285-92. PubMed ID: 8700135 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]